Evidence map›Paper›PMID 35528461›Full record

ArticleAmerican journal of clinical and experimental urology2022

Sex steroid modulation of macrophages within the prostate tumor microenvironment.

Zohra Berrehail, Clovis Boibessot, Typhaine Gris, France-Hélène Joncas, Fanny Gaignier, Chantal Guillemette, Louis Lacombe, Yves Fradet, Paul Toren

Open access · greenAbstract read
In one paragraph

Article in American journal of clinical and experimental urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zohra BerrehailCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Clovis BoibessotCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Typhaine GrisCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
France-Hélène JoncasCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Fanny GaignierCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Chantal GuillemetteCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Louis LacombeCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Yves FradetCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Paul TorenCHU de Québec-Université Laval Research Center Quebec City, Quebec, Canada.
Université Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of androgens and other sex steroids is known to influence the prognosis and progression of prostate cancer through different disease states. While androgens are generally regarded as immunosuppressive and estrogens as inflammatory, the specific influence of sex steroids on the immune microenvironment of prostate tumors remains incompletely understood. MATERIAL AND

methodsIn this study, we evaluate the link between sex steroids and prostate cancer immune cells, particularly macrophages. Using

results

conclusionsOur results highlight the complex influence of sex steroids on the immune cell composition of prostate tumors. Understanding this biology may help to further personalized therapy and improve patient outcomes.

Indexed as

immunosuppressive phenotypemacrophagesProstate cancersex steroidstumor microenvironment

Identifiers

PMID35528461
PMCPMC9077148
OpenAlexW4285741313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.